Avita Medical (RCEL)
(Delayed Data from NSDQ)
$5.47 USD
-0.07 (-1.26%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.49 +0.02 (0.37%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RCEL 5.47 -0.07(-1.26%)
Will RCEL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCEL
Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know
RCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RCEL
Is RCEL preparing to trend higher? New Uptrend shows up after sliding 1.26%
Is RCEL likely to continue higher? Non-ADX 1,2,3,4 Bullish shows up after crashing 5.06%
RCEL forms Upper Bollinger Band Walk on September 18
AVITA Medical: Reimbursement Reset And Breakeven Path By 2026
MACD Bullish Centerline Cross appears for RCEL after 7.54% move